Fig. 4

Effect of IL-6 on the EMT progress in HCC. a Phase-contrast images (left) and immunofluorescence images (right) of SK-Hep-1 cells stained using antibodies against E-cadherin or Vimentin after treated with or without 50 ng/ml IL-6 for 72 h. b Western-blot analysis of phenotypic markers after treated with or without 50 ng/ml IL-6 for 72 h in SK-Hep-1 cells